<DOC>
	<DOCNO>NCT02462876</DOCNO>
	<brief_summary>This study assess long term safety performance GORE® VIABAHN® Endoprosthesis treatment patient Popliteal Artery Aneurysms .</brief_summary>
	<brief_title>Evaluation GORE® VIABAHN® Endoprosthesis Treatment Popliteal Artery Aneurysm ( PAA )</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<criteria>Inclusion study require patient : 1 . Received GORE® VIABAHN® Endoprosthesis treat popliteal artery aneurysm 2 . Had symptomatic aneurysm asymptomatic aneurysm ( ≥ 2 cm diameter ) popliteal artery , presence mural thrombus ( &lt; 2 cm ) popliteal artery ; 3 . Was 18 year age old time treatment ; 4 . Had elective popliteal artery aneurysm procedure ; 5 . Has provide Informed Consent , personally lawful representation determine applicable local regulation state law Prior time implant patient / : 1 . Bilateral popliteal artery aneurysms initial treatment day ; 2 . Thrombotic occlusion popliteal artery PAA ; 3 . Marfan syndrome EhlersDanlos syndrome ; 4 . Unable tolerate antiplatelet therapy ; 5 . Thrombophilia require long term anticoagulation ; 6 . Known allergy GORE® VIABAHN® Endoprosthesis component ; 7 . Enrolled another investigational drug medical device trial participation may affect outcome treatment subject popliteal artery aneurysm study GORE® VIABAHN® Endoprosthesis previous surgery popliteal artery aneurysm study limb .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>